NCT00506402
- Conditions
- Agnogenic Myeloid Metaplasia, Anemia, Anemia, Refractory, +12 more
- Locations
-
- Princess Margaret Hospital Toronto, Canada
Clinical trial condition
Primary Myelofibrosis
Explore clinical trials studying Primary Myelofibrosis. Study availability and eligibility vary by location and protocol.
453 public trials
89 recruiting studies
Primary Myelofibrosis trial results
Active, Not Recruiting
Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant
NCT02506933
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, +43 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Study to Evaluate the Effect of Rabeprazole Sodium Enteric-coated Tablets on the Pharmacokinetics of TQ05105 Tablets
NCT07608666
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
- Locations
-
- The Third Xiangya Hospital, Central South University Changsha, Hunan, China
Active, Not Recruiting
P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk
NCT06468033
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
- Locations
-
- Levine Cancer Institute Charlotte, North Carolina, United States
- University of Yamanashi Hospital Chūō, Yamanashi, Japan
Active, Not Recruiting
Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)
NCT04603495
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers Chandler, Arizona, United States
- UC San Diego Moores Cancer Center La Jolla, California, United States
- USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
Active, Not Recruiting
Study of Tagraxofusp for Post-Transplant Maintenance for Patients With CD 123+ AML, MDS, MF and CMML (HSCT 002)
NCT05233618
- Conditions
- Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +16 more
- Locations
-
- Thomas Jefferson University Philadelphia, Pennsylvania, United States
- University of Virginia Charlottesville, Virginia, United States
Active, Not Recruiting
Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
NCT03862157
- Conditions
- Acute Myeloid Leukemia, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blood Coagulation Disorders, +43 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT04717414
- Conditions
- Anemia, Bone Marrow Diseases, Hematologic Diseases, +5 more
- Locations
-
- Local Institution - 110 Los Angeles, California, United States
- Local Institution - 135 Orlando, Florida, United States
- Local Institution - 133 Plantation, Florida, United States
- Local Institution - 112 Chicago, Illinois, United States
Active, Not Recruiting
Hu8F4 in Treating Patients With Advanced Hematologic Malignancies
NCT02530034
- Conditions
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Blast Crisis, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, +31 more
- Locations
-
- Augusta University Augusta, Georgia, United States
- Montefiore Medical Center, Albert Einstein College of Medicine The Bronx, New York, United States
- M D Anderson Cancer Center Houston, Texas, United States
- Huntsman Cancer Institute Salt Lake City, Utah, United States
Active, Not Recruiting
A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers
NCT04328844
- Conditions
- Adenoma, Bone Marrow Diseases, Eye Diseases, +34 more
- Locations
-
- Humanitas Research Hospital Rozzano, Milan, Italy
- Medical Oncology and Immunotherapy Unit, University Hospital of Siena Siena, Italy
- Beatson West of Scotland Cancer Centre Glasgow, United Kingdom